
News|Articles|December 16, 2025
Two-Step Monoclonal Antibody Purification Using a Multi-Column Continuous Chromatography Platform
Author(s)Tosoh Bioscience
Each additional step in monoclonal antibody (mAb) downstream bioprocessing increases operating expenses and reduces the recovery of precious product. This Application Note, demonstrates how Multi-Column Chromatography (MCC), an integral part of continuous biomanufacturing, reduces operating time, buffer consumption, and resin usage, thereby decreasing operating expenses.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
Charles River Incubator Cohort to Accelerate CGT Development
4
FAQ: Shifts in FDA Regulations and Strategies in 2025
5
